Clinical Trials Browser

Carcinoma, Renal Cell, Kidney Neoplasms

NCT03161756 2022-04-07

CHARLI

Phase 1/2 Unknown

72 enrolled

Dermatologic

Melanoma

NCT03732495 2022-03-29

LENVOS

Phase 2 Unknown

35 enrolled

EndocrineHead & Neck

Thyroid Cancer Metastatic

NCT03691311 2021-11-03

D-BIOMARK

Phase EARLY_PHASE1 Unknown

60 enrolled

Breast

Osteopetrosis, mild autosomal recessive form, Osteopetrosis, Autosomal Recessive 7, Breast Neoplasms

NCT04859569 2021-06-07

Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors

Phase 3 Unknown

850 enrolled

Other solid neoplasm

Bone Metastases From Solid Tumors

NCT04550949 2020-09-22

To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors

Phase 3 Unknown

700 enrolled

Bone Metastases

NCT04494373 2020-08-04

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

Phase 1 Unknown

154 enrolled

Other solid neoplasm

Bone Metastasis From Solid Tumors

NCT03605199 2019-08-26

Denosumab in Subjects With Giant Cell Rich Tumors of Bone

Phase 2 Unknown

60 enrolled

Chondroblastoma, Granuloma, Giant Cell, Bone Cysts, Aneurysmal, Osteoblastoma

NCT03811509 2019-01-28

B-ABLE

Phase 4 Unknown

1,000 enrolled

Breast

Breast Neoplasms, Osteoporosis, Arthralgia, Osteoporotic Fractures, Musculoskeletal Pain

NCT03259152 2017-08-24

D-Gct

Phase 3 Unknown

30 enrolled

Giant Cell Tumor of Bone

Clinical Trials

KEYPAD

CHARLI

LENVOS

D-BIOMARK

Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors

To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

Denosumab in Subjects With Giant Cell Rich Tumors of Bone

B-ABLE

D-Gct